Gilbert Halley E, a director at Arcutis Biotherapeutics Inc. ($ARQT), sold shares on the open market once in the last year, totaling about $456,000. His most recent sale occurred on November 20, 2025. This places him 6,662nd among 11,678 individual insiders by sale value, below the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | S | Common Stock | 16532 | $27.55 | 22,123.0000 | 132,885,000 | 42.77% | 0.01% |
| Nov. 20, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | M | Common Stock | 12220 | $7.51 | 38,655.0000 | 132,885,000 | 46.23% | 0.01% |
| Nov. 20, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | M | Stock Option (right to buy) | 12220 | $0.00 | 0.0000 | 132,885,000 | 100.00% | 0.01% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | A | Stock Option (right to buy) | 20568 | $0.00 | 20,568.0000 | 120,957,633 | 9999.99% | 0.02% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Director | A | Stock Option (right to buy) | 15372 | $0.00 | 28,872.0000 | 121,997,348 | 113.87% | 0.01% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Director | A | Common Stock | 3041 | $0.00 | 10,216.0000 | 121,997,348 | 42.38% | 0.00% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | A | Common Stock | 7609 | $0.00 | 26,435.0000 | 120,957,633 | 40.42% | 0.01% |
| June 11, 2025 | CytomX Therapeutics, Inc. | $CTMX | Gilbert Halley E | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 80,099,889 | 9999.99% | 0.05% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | A | Stock Option (right to buy) | 27052 | $0.00 | 27,052.0000 | 69,305,487 | 9999.99% | 0.04% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Gilbert Halley E | Director | A | Common Stock | 10139 | $0.00 | 18,826.0000 | 69,305,487 | 116.71% | 0.01% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Director | A | Stock Option (right to buy) | 7250 | $0.00 | 7,250.0000 | 97,157,690 | 9999.99% | 0.01% |
| June 6, 2024 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Director | A | Common Stock | 1550 | $0.00 | 7,175.0000 | 97,157,690 | 27.56% | 0.00% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Not found | M | Stock Option (Right to Buy) | 18200 | $0.00 | 30,374.0000 | 97,157,690 | 37.47% | 0.02% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Not found | S | Common Stock | 18200 | $73.00 | 5,625.0000 | 97,157,690 | 76.39% | 0.02% |
| June 3, 2024 | Vaxcyte, Inc. | $PCVX | Gilbert Halley E | Not found | M | Common Stock | 18200 | $5.35 | 23,825.0000 | 97,157,690 | 323.56% | 0.02% |
| May 15, 2024 | CytomX Therapeutics, Inc. | $CTMX | Gilbert Halley E | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |